---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-011595"
form_type: "8-K"
ticker: "BTAI"
cik: "0001720893"
company_name: "BioXcel Therapeutics, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:06:48.878215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BioXcel enters retention bonus agreements with key employees, CEO gets $650K after sNDA submission

## Summary
- CEO receives $650K bonus ($325K initial, $325K final); other key employees get $225K ($150K initial, $75K final).
- Final payment due April 15, 2026, contingent on continued employment and no default under Oaktree credit agreement.
- Final payment accelerates if company raises $25M+ capital or a change of control occurs before April 15, 2026.
- Employees must repay bonuses if terminated for cause or resign without good reason before Dec 31, 2026 (or Sep 30, 2026 if only initial paid).
- Agreements follow submission of sNDA for IGALMI for acute agitation in bipolar disorder or schizophrenia in outpatient setting.

## SEC filing metadata
- accession: 0001104659-26-011595
- form_type: 8-K
- ticker: BTAI
- cik: 0001720893
- company_name: BioXcel Therapeutics, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720893/000110465926011595/0001104659-26-011595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465926011595/tm265449d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-011595
- JSON: https://secwatch.observer/filing/0001104659-26-011595.json
- Plain text: https://secwatch.observer/filing/0001104659-26-011595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.